- Home
- TENX vs DRIO Comparison
TENX vs DRIO Comparison
Compare TENX & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- DRIO
- Stock Information
- Founded
- TENX 1967
- DRIO 2011
- Country
- TENX United States
- DRIO United States
- Employees
- TENX N/A
- DRIO N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- DRIO Medical/Dental Instruments
- Sector
- TENX Health Care
- DRIO Health Care
- Exchange
- TENX Nasdaq
- DRIO Nasdaq
- Market Cap
- TENX 25.0M
- DRIO 21.9M
- IPO Year
- TENX N/A
- DRIO N/A
- Fundamental
- Price
- TENX $5.99
- DRIO $9.55
- Analyst Decision
- TENX Strong Buy
- DRIO Strong Buy
- Analyst Count
- TENX 3
- DRIO 2
- Target Price
- TENX $15.00
- DRIO $50.00
- AVG Volume (30 Days)
- TENX 15.7K
- DRIO 14.8K
- Earning Date
- TENX 08-13-2025
- DRIO 08-12-2025
- Dividend Yield
- TENX N/A
- DRIO N/A
- EPS Growth
- TENX N/A
- DRIO N/A
- EPS
- TENX N/A
- DRIO N/A
- Revenue
- TENX N/A
- DRIO $27,148,000.00
- Revenue This Year
- TENX N/A
- DRIO $0.74
- Revenue Next Year
- TENX N/A
- DRIO $19.61
- P/E Ratio
- TENX N/A
- DRIO N/A
- Revenue Growth
- TENX N/A
- DRIO 41.79
- 52 Week Low
- TENX $3.25
- DRIO $7.60
- 52 Week High
- TENX $7.89
- DRIO $31.00
- Technical
- Relative Strength Index (RSI)
- TENX 51.19
- DRIO 41.90
- Support Level
- TENX $5.88
- DRIO $8.56
- Resistance Level
- TENX $6.02
- DRIO $11.14
- Average True Range (ATR)
- TENX 0.13
- DRIO 1.11
- MACD
- TENX -0.01
- DRIO 0.17
- Stochastic Oscillator
- TENX 70.37
- DRIO 48.75
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.